<DOC>
	<DOCNO>NCT01076699</DOCNO>
	<brief_summary>The purpose study determine RVX-100 safe effective treat acute abdominal pain patient irritable bowel syndrome accompany diarrhea .</brief_summary>
	<brief_title>A Four Arm Study Evaluate Safety Efficacy 3 Different Doses RVX-100 Versus Placebo Subjects With Irritable Bowel Syndrome Accompanied Diarrhea ( IBS-D )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Abdominal Pain</mesh_term>
	<criteria>Inclusion Criteria Adult male female , age ≥18 ≤75 year old . Subject/ legal representative able understand sign inform consent form . Have abdominal pain severity define weekly average `` bad abdominal pain past 24 hour '' score ≥ 3.0 0 10 point scale second week Baseline phase . Have IBSD accord Rome III criterion ≥25 % stool BSS inclusion criterion rat 6 7 Baseline phase . Not pregnant , lactating , breastfeed . If female childbearing potential , subject must agree remain abstinent practice two medically acceptable form contraception screening , baseline , treatment , withdrawal period . Acceptable form contraception include oral contraception , intrauterine device , implantable device , barrier method . If barrier method chosen , double barrier require . Discontinue medication use treat IBS symptom ( prescription nonprescription ) prescription analgesic least two ( 2 ) week prior start baseline period final study visit . ( Final study visit occur two ( 2 ) week last dose study medication . ) Acetaminophen may use rescue medication long carefully document Case Report Form ( CRF ) . Fiber supplement permit take frequency amount throughout study take four ( 4 ) week prior Baseline phase . This must document source document file CRF . Willing able comply studyrelated procedure , include incorporate significant change diet . Positive fecal ovum parasite ( O &amp; P ) Clostridium difficile ( ELISA ) bacterial pathogen ( standard stool culture ) Screening phase . Taking medication treatment IBS baseline phase ( acetaminophen ) . Taking treatment IBS include follow class medication within 2 week prior baseline visit ( Visit 2 ) , point study : Antispasmodic anticholinergic agent Combination product include atropine , hyoscyamine , phenobarbital , and/or scopolamine Antidepressants ( monoamine oxidase inhibitor [ MAOI ] , selective serotonin reuptake inhibitor [ SSRIs ] , tricyclic antidepressant ) , include , limited following : Combination product include pheniramine , phenyltoloxamine , pyrilamine Laxatives Opioids/narcotic analgesic Phenothiazines antipsychotic antiemetic History anticholinergic psychosis ( psychosis associate exposure anticholinergic medication ) . Laboratory value great three time upper limit normal ( ULN ) alanine transaminase ( ALT/SGPT ) aspartate transaminase ( AST/SGOT ) . Laboratory value great two time ULN total bilirubin ( TBil ) , creatinine ( sCr ) blood urea nitrogen ( BUN ) . Active infection hepatitis ( A , B , C ) positive confirmatory test HIV1 , HIV2 ( result HIV test keep strictly confidential . Subject may wish undergo HIV test per guideline HIV test requirement India pursuant NACO ) . History allergic reaction lhyoscyamine atropine , component formulation study drug . Evidence disease ( base medical history ) could adversely affect subject 's safety participation study interfere interpretation study result , include limited : glaucoma ; pyloric stenosis ; clinically significant benign prostatic hypertrophy ; clinically significant heart lung disease ; active peptic ulcer ; celiac disease ; digestive tract obstruction paralysis ; myasthenia gravis ; inflammatory bowel disease ; poorly control hypertension ; hyperthyroidism ; decrease hepatic renal function ; urinary retention , lactose intolerance . Use investigational drug within 30 day prior Baseline Visit ( Visit 2 ) , anytime study . History noncompliance treatment clinical visit attendance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>abdominal pain</keyword>
	<keyword>bloating</keyword>
	<keyword>diarrhea</keyword>
	<keyword>irritable bowel</keyword>
</DOC>